Sun Whistleblower Complaint to SEBl – 2: Huge Transactions between Aditya Medisales and Private Companies of Sun’s Promoters
In just over three years, between 2014 and 2017, Aditya Medisales Limited (AML) has had over Rs5,800 crore of transactions with Suraksha Realty, controlled by Sun Pharma’s co-promoter, Sudhir Valia, alleges the new 172-page complaint (with documents) sent by the whistleblower on Sun Pharma to the market regulator, Securities and Exchange Board of India (SEBI). 
 
Archived Premium Content
This article is outside your subscription period. You can buy this article individually.
SINGLE ARTICLE
Rs 50-Rs 100 + GST
Access will be given ONLY to this article.
 
Already a subscriber ? Log in
Free Helpline
Legal Credit
Feedback